{"organizations": ["Novartis", "Reuters"], "uuid": "be0f4085b8a376cc5a168d3a75b275d983b6c2f8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.newsdump.com", "main_image": "", "site_section": "http://www.newsdump.com/feed/", "section_title": "NewsDump.com, US News, Headlines, Latest USA News, US Sports, US Politics, Football, Business, Celebs, Baseball, Hockey, Basketball", "url": "http://www.newsdump.com/article/novartis-broadens-cancer-immune-therapy-pipeline-with-acquisition-licensing-pacts", "country": "CZ", "title": "Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts", "performance_score": 0, "site": "newsdump.com", "participants_count": 0, "title_full": "Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts", "spam_score": 0.0, "site_type": "news", "published": "2015-10-21T08:26:00.000+03:00", "replies_count": 0, "uuid": "be0f4085b8a376cc5a168d3a75b275d983b6c2f8"}, "author": "", "url": "http://www.newsdump.com/article/novartis-broadens-cancer-immune-therapy-pipeline-with-acquisition-licensing-pacts", "ord_in_thread": 0, "title": "Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Published By: Reuters - Health - Today \nZURICH (Reuters) - Novartis said it broadened its immuno-oncology pipeline with the acquisition of Admune Therapeutics and licensing agreeme... Read Full Story ... Related articles:", "external_links": [], "published": "2015-10-21T08:26:00.000+03:00", "crawled": "2015-10-21T10:24:44.418+03:00", "highlightTitle": ""}